No Data
No Data
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
JP Morgan Maintains Overweight on IQVIA Hldgs, Raises Price Target to $288
IQVIA Hldgs Analyst Ratings
Does IQVIA Holdings (NYSE:IQV) Deserve A Spot On Your Watchlist?
Express News | IQVIA Holdings Inc : JP Morgan Raises Target Price to $288 From $260